sucrose has been researched along with Hemarthrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, P; Enriquez, MM; Faradji, A; Morfini, M; Schwartz, L | 1 |
| Aledort, LM | 1 |
| Aledort, LM; Navickis, RJ; Wilkes, MM | 1 |
1 trial(s) available for sucrose and Hemarthrosis
| Article | Year |
|---|---|
Efficacy and safety of secondary prophylactic vs. on-demand sucrose-formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13-month crossover study.
Topics: Adult; Chemistry, Pharmaceutical; Coagulants; Cross-Over Studies; Drug Administration Schedule; Europe; Factor VIII; Hemarthrosis; Hemophilia A; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Secondary Prevention; Severity of Illness Index; Sucrose; Time Factors; Treatment Outcome; United States | 2010 |
2 other study(ies) available for sucrose and Hemarthrosis
| Article | Year |
|---|---|
To bleed or not to bleed - is that a question?
Topics: Coagulants; Drug Administration Schedule; Factor VIII; Hemarthrosis; Hemophilia A; Home Infusion Therapy; Humans; Infusions, Intravenous; Secondary Prevention; Severity of Illness Index; Sucrose; Time Factors; Treatment Outcome | 2010 |
Best evidence on B-domain deletion and the immunogenicity of recombinant factor VIII.
Topics: Autoantibodies; Clinical Trials as Topic; Coagulants; Factor VIII; Hemarthrosis; Hemophilia A; Home Infusion Therapy; Humans; Immunogenetic Phenomena; Male; Secondary Prevention; Sucrose | 2011 |